Evaluating the Implementation and Impact of Navigator-delivered ePRO Home Symptom Monitoring and Management
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 3,090
- 试验地点
- 1
- 主要终点
- Service Penetration
研究概览
简要总结
Evaluate implementation of navigator-delivered Home ePRO for all cancer patients across multiple practice sites and assess the impact of Home ePRO on clinical and utilization outcomes.
详细描述
Randomized controlled trials demonstrated that weekly electronic home-based PRO symptom monitoring with automated alerts to clinicians (Home ePRO) in cancer patients was associated with reduced healthcare utilization, improved quality of life, and increased overall survival. However, these trials were administered using infrastructure supported by research funding. A knowledge gap remains about optimal implementation strategies for and effectiveness of Home ePROs in real-world settings. To address this gap, we will conduct a large-scale population-based implementation of an evidence-based Home ePRO intervention for all adult cancer patients receiving chemotherapy. The investigators' hypothesis is that the implementation of navigator-delivered Home ePRO will be successful and will improve both patient and health system outcomes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient Group:
- •Cancer patients at participating institution
- •Receipt of chemotherapy, targeted therapy, and immunotherapy at participating institution from 2019-2026.
排除标准
- •- Second opinion only at participating institution.
研究组 & 干预措施
Patient Group
Patients from UAB/MCI enrolled
干预措施: Navigator-delivered Home ePRO (Other)
结局指标
主要结局
Service Penetration
时间窗: 5 years
% of eligible patients enrolled
Service Penetration
时间窗: up to 3 months of starting a treatment for cancer
% of eligible patients enrolled
次要结局
- Proportion of Alerts Closed Within 48 Hours(up to 48 hours)
- % of Patients Completing ≥1 ePRO Survey(up to 6 months)
- % of Expected ePRO Surveys Completed Per Patient(up to 6 months)
- % of Surveys Completed of Surveys Sent to Patient(up to 6 months)
- Symptom Trajectory(up to 3 months; up to 6 months)
- Number of ED Visits(up to 3 months, up to 6 months)
- Number of Hospitalizations(up to 3 months, up to 6 months)
- Number of ICU Visits(up to 3 months, up to 6 months)
- Total Cost of Care(up to 3 months, up to 6 months)
研究者
Gabrielle Rocque
Associate Professor of Medicine, Division of Hematology & Oncology; Division of Gerontology, Geriatrics, & Palliative Care
University of Alabama at Birmingham